RAF BEX SRL
RAF BEX reported total assets of 651,970 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Oct 2026).
The score of RAF BEX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +55 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RAF BEX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,124 € | ||||
| Equity | 272,739 € | ||||
| Cash | 124,674 € | ||||
| EBITDA | 88,798 € | ||||
| Total assets | 651,970 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Oct 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
RAF BEX's financial analysis
- Solvency41.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RAF BEX
RAF BEX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0884.573.088
- VAT number
- BE0884573088
- Peppol
- Registered · 0208:0884573088 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Oct 2006
- Registered office
- 3000 Leuven
- Latest accounts
- 2025 · filed on 05 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
RAF BEX (SRL) has been based in Leuven since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,124 € and equity of 272,739 €; its revenue is not published. Its solvency stands at 41.8%, below the median of its sector (44.2%).
Companies similar to RAF BEX
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Berckenbosch Retail sale of pharmaceutical products Leuven · balance sheet 652,803 €
- Pharmacie de Cherain Retail sale of pharmaceutical products Gouvy · balance sheet 658,226 €
- Apoteek Staes Retail sale of pharmaceutical products Diest · balance sheet 650,270 €
- Daluphar Retail sale of pharmaceutical products Anderlecht · balance sheet 651,365 €
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
- Curavaleas Retail sale of pharmaceutical products Antwerp · balance sheet 650,626 €
- Geva Pharma Retail sale of pharmaceutical products Oudenaarde · balance sheet 655,182 €
- Bella Donna Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 655,308 €
Frequently asked questions about RAF BEX
What is the revenue of RAF BEX?
RAF BEX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RAF BEX?
In Belgium, the VAT number is the company number prefixed with BE: BE0884573088 for RAF BEX, if the company is VAT-registered. Its company number (CBE) is 0884.573.088.
Where is the registered office of RAF BEX?
According to the CBE register, the registered office of RAF BEX is in 3000 Leuven.
What is the equity of RAF BEX?
At the close of the 2025 financial year, the equity of RAF BEX amounts to 272,739 €, a solvency of 41.8% of total assets.
Who manages RAF BEX?
The register lists 1 active mandates at RAF BEX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of RAF BEX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →